213 related articles for article (PubMed ID: 15837972)
1. Chemotherapy alone for early Hodgkin's lymphoma: an emerging option.
Canellos GP
J Clin Oncol; 2005 Jul; 23(21):4574-6. PubMed ID: 15837972
[No Abstract] [Full Text] [Related]
2. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
Lopez M
Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542
[No Abstract] [Full Text] [Related]
3. How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?
Canellos GP; Duggan D; Johnson J; Niedzwiecki D
J Clin Oncol; 2004 Apr; 22(8):1532-3. PubMed ID: 15084636
[No Abstract] [Full Text] [Related]
4. Hodgkin's lymphoma--the great teacher.
Connors JM
N Engl J Med; 2011 Jul; 365(3):264-5. PubMed ID: 21774715
[No Abstract] [Full Text] [Related]
5. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
Meyer RM; Gospodarowicz MK; Connors JM; Pearcey RG; Bezjak A; Wells WA; Burns BF; Winter JN; Horning SJ; Dar AR; Djurfeldt MS; Ding K; Shepherd LE; ;
J Clin Oncol; 2005 Jul; 23(21):4634-42. PubMed ID: 15837968
[TBL] [Abstract][Full Text] [Related]
6. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
7. ABVD chemotherapy of Hodgkin's disease.
Molnár Z; Schneider T; Várady E; Fleischmann T
Neoplasma; 1997; 44(4):263-5. PubMed ID: 9473781
[TBL] [Abstract][Full Text] [Related]
8. Pohl-Pinkus constrictions of hair following chemotherapy for Hodgkin's disease.
Williamson PJ; de Berker D
Br J Haematol; 2005 Mar; 128(5):582. PubMed ID: 15725077
[No Abstract] [Full Text] [Related]
9. Greater curability in advanced Hodgkin's disease?
Portlock CS
Cancer J Sci Am; 1999; 5(5):264-5. PubMed ID: 10526665
[No Abstract] [Full Text] [Related]
10. Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.
Engert A; Franklin J; Eich HT; Brillant C; Sehlen S; Cartoni C; Herrmann R; Pfreundschuh M; Sieber M; Tesch H; Franke A; Koch P; de Wit M; Paulus U; Hasenclever D; Loeffler M; Müller RP; Müller-Hermelink HK; Dühmke E; Diehl V
J Clin Oncol; 2007 Aug; 25(23):3495-502. PubMed ID: 17606976
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy alone for early-stage Hodgkin's lymphoma.
Straus DJ
N Engl J Med; 2012 Feb; 366(5):470-1. PubMed ID: 22149920
[No Abstract] [Full Text] [Related]
12. Hodgkin's disease of appendix: report of a case.
Umer MA; Date RS; Mellor S; Nair B; Ward JB
Colorectal Dis; 2009 Nov; 11(9):985-7. PubMed ID: 19175635
[TBL] [Abstract][Full Text] [Related]
13. Current role and future developments of radiotherapy in early-stage favourable Hodgkin's lymphoma.
Eich HT; Müller RP
Strahlenther Onkol; 2007 Dec; 183 Spec No 2():16-8. PubMed ID: 18167000
[No Abstract] [Full Text] [Related]
14. Combined modality treatment of Hodgkin's lymphoma.
Klimm B; Engert A
Cancer J; 2009; 15(2):143-9. PubMed ID: 19390310
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin's disease associated cholestasis in a man with thymoma.
Opeskin K; Burke M; McCaffrey G; Nandurkar H
Pathology; 2003 Aug; 35(4):349-51. PubMed ID: 12959773
[No Abstract] [Full Text] [Related]
16. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
[TBL] [Abstract][Full Text] [Related]
17. Controversies in the treatment of early-stage Hodgkin's lymphoma.
Longo DL; Armitage JO
N Engl J Med; 2015 Apr; 372(17):1667-9. PubMed ID: 25901431
[No Abstract] [Full Text] [Related]
18. Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group.
Arakelyan N; Berthou C; Desablens B; de Guibert S; Delwail V; Moles MP; Quittet P; Jais JP; Colonna P; Andrieu JM;
Cancer; 2008 Dec; 113(12):3323-30. PubMed ID: 18988286
[TBL] [Abstract][Full Text] [Related]
19. Marathon running during chemotherapy: where are the limits?
Dimeo FC
Onkologie; 2011; 34(5):230. PubMed ID: 21577027
[No Abstract] [Full Text] [Related]
20. Marathon run under chemotherapy: is it possible?
Bernhörster M; Rosenhagen A; Vogt L; Thiel C; Jäger E; Banzer W
Onkologie; 2011; 34(5):259-61. PubMed ID: 21577032
[No Abstract] [Full Text] [Related]
[Next] [New Search]
